Summit Therapeutics Balance Sheet (2014-2026) | SMMT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	103.40M		71.79M			121.97M	348.61M	70.97M	42.12M	23.79M	71.42M	61.29M	28.43M	93.78M	104.86M	211.53M	297.87M	238.55M	225.27M	106.52M
Short-term Investments (Quarter)							300.00M	170.96M	172.90M			0.32M	0.32M	0.32M	307.49M	0.32M		0.32M	0.32M	0.32M
Cash & Current Investments (Quarter)	103.40M		71.79M			121.97M	648.61M	241.93M	215.01M	23.79M	71.42M	61.61M	28.75M	94.10M	412.35M	211.84M	297.87M	238.88M	225.58M	106.83M
Receivables - Net (Quarter)	1.05M	2.29M	1.46M	0.87M	0.24M	0.14M	0.35M
Receivables - Other (Quarter)			0.57M	0.56M	1.11M								0.05M	0.09M		0.01M
Receivables (Quarter)	1.05M	2.29M	2.04M	1.43M	1.35M	0.14M	0.35M
Prepaid Assets (Quarter)	0.96M	8.41M	1.20M	1.48M	5.39M	0.43M	0.49M	1.19M	6.09M	5.07M	2.62M	5.32M	2.05M	2.41M	11.08M	9.12M	11.05M	7.59M	6.54M	17.55M
Current Assets (Quarter)	121.48M	102.21M	97.31M	99.44M	79.40M	137.12M	656.71M	248.03M	227.50M	204.95M	189.71M	163.26M	328.79M	490.29M	423.75M	370.75M	309.24M	246.47M	720.30M	616.60M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.76M	0.66M	0.69M	0.96M	1.09M	0.93M	0.91M	0.41M	0.23M	0.23M	0.20M	0.18M	0.22M	0.27M	0.25M	0.65M	0.69M	0.81M	1.06M	1.66M
Goodwill (Quarter)	2.06M	2.00M	2.01M	1.95M	1.81M	1.66M	1.80M	1.84M	1.88M	1.81M	1.89M	1.88M	1.88M	1.99M	1.86M	1.92M	2.04M	2.00M	2.00M	1.97M
Intangibles (Quarter)	11.16M	10.61M	10.40M	9.87M	8.90M	7.95M
Goodwill & Intangibles (Quarter)	13.22M	12.61M	12.41M	11.82M	10.71M	9.61M	1.80M	1.84M	1.88M	1.81M	1.89M	1.88M	1.88M	1.99M	1.86M	1.92M	2.04M	2.00M	2.00M	1.97M
Other Non-Current Assets (Quarter)			0.17M	0.17M	0.18M	0.14M	0.58M	0.16M	0.25M	4.33M	4.32M	1.88M	1.88M	1.86M	2.55M	4.14M	6.52M	7.03M	7.21M	8.23M
Non-Current Assets (Quarter)	24.04M	26.46M	16.06M	17.04M	16.32M	18.21M	7.46M	6.87M	9.87M	13.53M	13.24M	13.52M	13.06M	12.56M	11.81M	13.07M	14.80M	15.26M	30.88M	31.26M
Assets (Quarter)	145.52M	128.67M	113.37M	116.47M	95.72M	155.33M	664.17M	254.90M	237.37M	218.48M	202.95M	176.78M	341.86M	502.85M	435.56M	383.82M	324.04M	261.73M	751.18M	647.86M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	6.95M	5.88M	4.37M	6.96M	3.57M	1.43M	0.35M	0.71M	0.99M	3.31M	2.67M	6.37M	3.34M	3.25M	4.64M	4.99M	22.98M	22.25M	20.29M	27.55M
Notes Payables (Quarter)							19.77M			100.00M			100.00M	24.50M
Payables (Quarter)	6.95M	5.88M	4.37M	6.96M	3.57M	1.43M	20.12M	0.71M	0.99M	103.31M	2.67M	6.37M	103.34M	27.75M	4.64M	4.99M	22.98M	22.25M	20.29M	27.55M
Accumulated Expenses (Quarter)	6.13M	7.43M	4.12M	7.57M	1.91M	11.14M	10.66M	12.30M	3.53M	3.51M	5.43M	6.03M	4.88M	18.48M	19.55M	4.40M	26.15M	10.96M	32.10M	7.07M
Other Accumulated Expenses (Quarter)	0.66M	1.03M	0.90M	0.68M	0.27M	0.21M	0.66M	0.32M	0.62M	0.48M	0.72M	0.79M	0.81M	1.03M	1.80M	0.76M	1.49M	1.96M	2.28M	1.15M
Short term Debt (Quarter)
Current Leases (Quarter)	1.01M	0.94M	1.09M	0.91M	0.68M	1.39M	1.69M	1.69M	2.93M	2.78M	2.81M	3.70M	3.69M	3.79M	3.77M	3.54M	3.12M	2.72M	3.39M	3.18M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)	7.14M	7.51M	7.94M	5.10M	3.23M
Total Current Liabilities (Quarter)	21.89M	22.79M	25.62M	22.72M	15.17M	16.68M	38.78M	17.44M	11.93M	113.74M	20.41M	23.44M	140.17M	59.01M	41.73M	34.88M	60.33M	64.93M	72.99M	83.27M
Non-Current Liabilities
Non-Current Debt (Quarter)				25.05M	25.31M		494.54M	100.00M	100.00M		100.00M	100.00M
Non-Current Deffered Revenue (Quarter)	0.36M
Liabilities from Discontinued Operations (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	1.15M	0.90M	1.69M	1.53M	1.32M	2.97M	2.76M	2.49M	4.33M	3.88M	3.29M	5.82M	5.02M	4.21M	3.45M	2.91M	2.44M	2.71M	17.50M	16.86M
Other Non-Current Liabilities (Quarter)	2.69M	2.69M	2.78M	2.75M	2.59M	2.42M	1.43M	1.48M	1.51M	1.48M	1.56M	3.31M	1.60M	1.72M	1.63M	1.71M	1.84M	1.83M	1.83M	1.80M
Total Non-Current Liabilities (Quarter)	23.40M	23.68M	27.31M	49.31M	41.81M	19.66M	536.09M	119.93M	116.26M	117.62M	123.69M	129.26M	145.19M	63.22M	45.18M	37.78M	62.76M	67.64M	90.49M	100.12M
Total Liabilities (Quarter)	26.09M	26.38M	30.09M	52.06M	44.40M	22.08M	537.51M	121.42M	117.77M	119.10M	125.26M	132.57M	146.78M	64.93M	46.81M	39.49M	64.60M	69.47M	92.32M	101.92M
Shareholder's Equity
Total Debt (Quarter)				25.05M	25.31M		494.54M	100.00M	100.00M		100.00M	100.00M
Common Equity (Quarter)	119.43M	102.30M	83.28M	64.41M	51.32M	133.25M	126.65M	133.48M	119.60M	99.38M	77.69M	44.21M	195.07M	437.92M	388.75M	344.33M	259.44M	192.26M	658.86M	545.93M
Shareholder's Equity (Quarter)	119.43M	102.30M	83.28M	64.41M	51.32M	133.25M	126.65M	133.48M	119.60M	99.38M	77.69M	44.21M	195.07M	437.92M	388.75M	344.33M	259.44M	192.26M	658.86M	545.93M
Liabilities and Shareholders Equity (Quarter)	145.52M	128.67M	113.37M	116.47M	95.72M	155.33M	664.17M	254.90M	237.37M	218.48M	202.95M	176.78M	341.86M	502.85M	435.56M	383.82M	324.04M	261.73M	751.18M	647.86M
Retained Earnings (Quarter)	-252.90M	-3.44M	-299.55M	-320.94M	-3.17M	-359.10M	-378.33M	-920.71M	-935.42M	-956.69M	-2.45M	-1036.73M	-2.50M	-2.31M	-1214.57M	-1277.49M	-2.75M	-2074.99M	-2.54M	-2483.58M
Treasury Shares (Quarter)																				0.73M

Research Tools

Developers

Summit Therapeutics Balance Sheet (2014-2026) | SMMT

Research Tools

Developers

Summit Therapeutics Balance Sheet (2014-2026) | SMMT

Create an account

Sign In

Reset Password